The H 1-histamine antagonist dithiaden inhibits human platelet function in vitro

Platelets

Volumn 8, Issue 2-3, 1997, Pages 175-180

  Nosal' R ^a   Jancinova V ^b   Danihelova, E ^c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^c Inst Haematol and Transfusiology   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; CALCIMYCIN; DITHIADEN; HISTAMINE H1 RECEPTOR ANTAGONIST; MEMBRANE PHOSPHOLIPID; THROMBIN; THROMBOXANE B2;

ADULT; ARTICLE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0030816293     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109777447     Document Type: Article

References (35)

1. DaPrada M, Picotti GB, Kettler R, Launay JM. Serotonin, histamine, catecholamines, normetanephrine and octopamine in blood platelets. In: Rotman A, Meyer FA, Gitler C, Silberberg A, eds. Platelets; Cellular Responses Mechanisms and their Biological Significance. Chichester: John Wiley & Sons Ltd, New York, 1980; 277-88.
2. DaPrada M, Richards JG, Kettler R. Amine storage organelles in platelets. In: Gordon JL, ed. Platelets in Biology and Pathology II. Amsterdam: Elsevier/North Holland Press, 1981: 105-45.
3. Graham HT, Lowry OH, Wheelwrite FL, Lenx D, Parish H. Distribution of histamine among leukocytes and platelets. Blood 1955; 10: 467-81.
4. Saxena SP, McNicol A, Brandes LJ, Becker AB, Gerrard JM. Histamine formed in stimulated human platelets is cytoplasmic. Biophys Res Commun 1989; 164: 164-8.
5. Saxena SP, Brandes JL, Becker AB, Simons J, LaBella FS, Gerrard JM. Histamine is an intracellular messenger mediating platelet aggregation. Science 1989; 243: 1596-9.
6. Hillis LD, Lange RA. Serotonin and acute ischemic heart disease. New Engl J Med 1991; 324: 68-90.
7. Gill DS, Thompson CS, Barradas MA, Dandona P. The effect of histamine antagonists on aortic permeability and histamine metabolism in streptozotocin-induced diabetes mellitus in the rat. Clin Sci 1990; 78: 39P.
8. Wu NZ, Baldwin AL. Transient venular permeability and endothelial gap formation induced by histamine. Am J Physiol 1992; 262: H1238-47.
9. Gill DS, Barradas MA, Fanseca VA, Gracey L, Dandona P. Increased histamine content in leukocytes and platelets of patients with peripheral vascular disease. Am J Clin Pathol 1988; 89: 622-6.
10. Jančinová V, Nosál' R. Cimetidine and ketotifen inhibit stimulated aggregation and histamine liberation from rabbit blood platelets. Agents Act 1989; 27: 135-7.
11. Nosál' R, Jančinová V, Petríková M. Antihistaminic drug bromadryl and stimulated platelet aggregation. Agents Act 1994; 41: C104-5.
12. 1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation malondialdehyde formation and thromboxane production in vitro Inflamm Res 1995; 44: S14-5.
13. Jančinová V, Petríková M, Májeková M. Nosál' R. Effect of pheniramine, chlorpheniramine and brompheniramine on stimulated blood platelets: Structure-activity relationship. Inflamm Res 1995; 44: S38-9.
14. Jančinová V, Petríková M, Nosál' R. The antihistamine drug cimetidine and arachidonic acid metabolism. Agents Act (Special Conference Issue) 1992; C434-6.
15. Nosál' R, Jančinová V, Petríková M. Effect of antihistaminics on stimulated blood platelet functions. Čs Fyziol 1995; 44: 21-3.
16. 1-histamine antagonist dithiaden inhibits human platelets in vitro. Inflamm Res 1996; 45: S29-30.
17. 2-adrenergic receptor mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve. Mol Pharmacol 1985; 27: 1-9.
18. 2-adrenoceptor agonists and of related compounds on aggregation and adenylate cyclase activity in human platelets. Br J Pharmacol 1984; 82: 467-76.
19. Colman RW. Platelet activation: role of an ADP receptor. Sem Hematol 1986; 23: 119-28.
20. Stormorken H, Lyberg T, Kakvaag L, Nakstad B. Dissociation of the aggregating effect and the inhibitory effect upon cyclic adenosine monophosphate accumulation by adrenaline and adenosine diphosphate in human platelets. Thromb Res 1987; 457: 363-70.
21. Takamatsu JM, Home III MK, Graluick HR. Identification of the thrombin receptor on human platelets by chemical crosslinking. J Clin Invest 1986; 77: 362-8.
22. Phillips DR, Agin PP. Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochem Biophys Res Commun 1977; 75: 940-76.
23. Rittenhouse-Simons S. Differential activation of platelet phospholipase by thrombin and ionophore A23187. J Biol Chem 1987; 256: 4153-4165.
24. Nosál' R, Jančinová V, Petríková M. The role of intracellular calcium in A23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets. Biochem Pharmacol 1994; 47: 2207-11.
25. Jančinová V, Nosál' R. Difference among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation. Thromb Res 1989; 54: 687-98.
26. Nosál' R, Jančinová V, Petríková M. Chloroquine inhibits stimulated platelets at the arachidonic acid pathway. Thromb Res 1995; 77: 531-42.
27. Nosál' R, Petríková M, Jančinová V. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with β-adrenoceptor blocking drugs. J Lipid Med 1993; 8: 121-32.
28. Hamberg M, Svensson J, Samuelson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-8.
29. Joshi UM, Kodavanti PRS, Lockhard VG, Mehendale HM. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Biochim Biophys Acta 1989; 1004: 309-20.
30. Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorders. Pharmacol Rev 1990; 42: 327-54.
31. Pappu A, Hosteller KY. Effect of cationic amphiphilic drugs on the hydrolysis of acidic and natural phospholipids by liver phospholipase A. Biochem Pharmacol 1984; 33: 1639-44.
32. 32P-incorporation into and arachidonic acid liberation from phospholipids in stimulated mast cells. Agents Act 1989; 27: 29-32.
33. Nozawa Y, Nakashima S, Nagata K. Phospholipid-mediated signalling in receptor activation in human platelets. Biochim Biophys Acta 1991; 1082: 219-38.
34. Launay JM, Bondoux D, Oset-Gasque MI, Emami S, Mutel V, Haimart M. Increase of human platelet serotonin uptake by atypical histamine receptors. Am J Physiol 1994; 266: 526-36.
35. 2 synthesis in canine whole blood. Feder Proc 1983; 42: 640-5.